1. Novel biomarkers for the diagnosis and prognosis of gallbladder cancer
   Hong Ze Lin et al, 2021, Journal of Digestive Diseases CrossRef
2. Discoidin Domain Receptors in Lung Cancer
   Yingtao Zhang et al, 2016, Discoidin Domain Receptors in Health and Disease CrossRef
3. DDR2 and IFITM1 Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas
   Daiqiang Li et al, 2019, Pathology & Oncology Research CrossRef
4. Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways
   Mark L. Grimes et al, 2013, PLoS ONE CrossRef
5. A review of predictive, prognostic and diagnostic biomarkers for non-small-cell lung cancer: towards personalised and targeted cancer therapy
   Ernest Osei et al, 2020, Journal of Radiotherapy in Practice CrossRef
6. Discoidin Domain Receptor 2 Signaling Networks and Therapy in Lung Cancer
   Leo S. Payne et al, 2014, Journal of Thoracic Oncology CrossRef
7. Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients
   HIDEAKI YASHIMA et al, 2014, Molecular and Clinical Oncology CrossRef
8. Potentially functional variants of PARK7 and DDR2 in ferroptosis‐related genes predict survival of non‐small cell lung cancer patients
   Huilin Wang et al, 2024, International Journal of Cancer CrossRef
9. Landscape of targeted therapies for lung squamous cell carcinoma
   Qiuxuan Chen et al, 2024, Frontiers in Oncology CrossRef
10. Perspective Chapter: Molecular Pathology of Lung Cancer
    Shivani Gandhi et al, 2023, Molecular Histopathology and Cytopathology CrossRef
11. Squamous cell lung cancer: Current landscape and future therapeutic options
    Sally C.M. Lau et al, 2022, Cancer Cell CrossRef
12. Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients
    Mi-Sook Lee et al, 2017, Cancer Research and Treatment CrossRef
13. In-silico Approach to Investigate the Phytochemicals of Terminalia arjuna as Multitarget Inhibitors of Proteins Involved with Lung Cancer
    Tathagata Adhikary et al, 2024, Letters in Drug Design & Discovery CrossRef
14. Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis
    Chenlu Wu et al, 2022, Journal of Cancer Research and Clinical Oncology CrossRef
15. Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications
    A. Quintanal-Villalonga et al, 2016, Disease Markers CrossRef
16. Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients
    Liyun Miao et al, 2014, BMC Cancer CrossRef
17. Beyond EGFR and ALK inhibition: Unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer
    Raffaele Califano et al, 2015, Cancer Treatment Reviews CrossRef